
A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra ®) For The Treatment of Ankylosing Spondylitis In Nine European Countries
Rencz, F, Brodszky,, Péntek, M, Gulacsi, L, Baji, PVolume:
19
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.1124
Date:
November, 2016
Fichier:
PDF, 64 KB
english, 2016